共 50 条
- [31] Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis JOURNAL OF CROHNS & COLITIS, 2015, 9 : S283 - S283
- [34] Improvement of Disability in Ulcerative Colitis Patients Aft er One Year With Anti-TNF Agents AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S22 - S22
- [35] Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patients JOURNAL OF CROHNS & COLITIS, 2018, 12 : S298 - S298
- [36] Anti-TNF alpha as induction and maintenance therapy in ulcerative colitis patients in the BioColitis Registry in Germany JOURNAL OF CROHNS & COLITIS, 2016, 10 : S292 - S293
- [37] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study JOURNAL OF CROHNS & COLITIS, 2019, 13 : S400 - S401
- [39] Treatment Persistence Among Anti-TNF-Experienced Patients With Ulcerative Colitis Switching to Ustekinumab or Cycling to Another Anti-TNF Agent AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S13 - S13